Yahoo Web Search

Search results

  1. 1 day ago · Novartis has been advancing the scientific understanding and treatment of CVD for more than four decades. Through early intervention, pioneering science and technological innovation, we are addressing factors that increase the risk of heart attacks and strokes, improving the function of damaged hearts and easing the burden of care for patients.

    • Careers

      About. Novartis is an innovative medicines company. Every...

    • Investors

      About. Novartis is an innovative medicines company. Every...

    • Contacts

      Contacts - Novartis new innovative therapy lowers bad...

    • About

      Learn more about Novartis and explore our core therapeutic...

    • Patients & Caregivers

      Patients & Caregivers - Novartis new innovative therapy...

    • News

      Novartis announced it has partnered with Versant Ventures...

  2. 3 days ago · Phase II data presented Sunday at the American Society for Radiation Oncology annual meeting suggest Novartis’ Lutathera may improve progression-free survival in patients with tough-to-treat meningioma brain tumors. Lutathera is a combination of a radionuclide, 177Lu, and a peptide that binds to somatostatin receptors.

  3. 2 days ago · Novartis AG (NYSE:NVS) remains a solid big pharmaceutical company to invest in the long term. The reason, it continues to have several products in its pipeline with double-digit growth. Especially ...

  4. 4 days ago · Novartis’ head of drug development talks about its stake in CAR-T immunotherapy. These cell therapies are set to transform treatment of blood cancers – but questions about safety ...

  5. 5 days ago · Get Novartis AG (NOVN.S) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

  6. 3 days ago · Research Novartis' (SWX:NOVN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.

  7. 3 days ago · Novartis's strategic focus on innovative pharmaceutical products positions the company for potential long-term growth. The company's pure-play pharma approach allows for more targeted research and development efforts, potentially leading to breakthrough therapies in high-need areas.

  1. People also search for